Whalegun
Home

Alnylam Pharmaceuticals ALNY paid The McManus Group $50K for lobbying in Q4 2023 · Medicare, Health Issues

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q4 2023
Stock
Alnylam Pharmaceuticals ALNY
Client
Alnylam Pharmaceuticals
Reported
24/01/20

Down 16.7% from last quarter

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Alnylam Pharmaceuticals's other lobbying reports